Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: CSPC PHARMA(01093) the Revenue is 14.13 B (+107.4%), Beat estimate;the EBIT is 7.43 B (+542.6%), Beat estimate;the EPS is 0.534 (+422.9%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
14.13B107.44%
10.11B48.53%
+4.01B58.91%
EBITExceed expectations
7.43B542.60%
3.77B226.40%
+3.66B316.20%
EPSExceed expectations
0.5337422.91%
0.3585251.26%
+0.1752171.65%
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf